Active	Status	Sponsor type	Region	Phase	Filter
12 Active 22 Inactive 34 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Grange, Dorothy K
EDELIFE, NCT04980638 / 2021-002532-23: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia	Recruiting	2	20	Europe, US	ER004	EspeRare Foundation, Pierre Fabre Medicament, Iqvia Pty Ltd	X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)	04/25	01/29
NCT05795361: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome	Available	N/A		Europe, US, RoW	Idursulfase-IT, HGT-2310, TAK-609	Takeda	Hunter Syndrome
Siminerio, Linda
NCT04678661: My Dose Coach Mobile App to Support Insulin Titration and Maintenance	Terminated	N/A	60	US	Smartphone application and web portal, My Dose Coach, Standard Insulin Therapy Education	Linda Siminerio, Sanofi	Diabetes Mellitus Type 2 - Insulin-Treated	12/22	02/23
Libman, Ingrid
NCT04628481 / 2020-001926-71: A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function	Active, not recruiting	2	140	Europe, US, RoW	Ladarixin, allosteric inhibitor of CXCL8 (IL-8), CXCR1 and CXCR2 receptors, Placebo	Dompé Farmaceutici S.p.A, Dompe farmaceutici s.p.a.	Recent Onset type1 Diabetes	04/24	04/26
NCT05743244: Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)	Recruiting	2	78	US	Abrocitinib 200 MG Oral Tablet, CIBINQO, Ritlecitinib, Placebo	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pfizer	Diabetes Mellitus, Type 1	06/26	06/27
Triulzi, Darrell
NCT03633604: Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia	Available	N/A		US	HBOC-201, Hemopure, hemoglobin glutamer - 250 (bovine)	Jonathan H. Waters, HbO2 Therapeutics LLC	Anemia Severe
McCormick, Meghan
No trials found